Clinical and Translational Allergy (Oct 2017)
CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report
- J. Bousquet,
- G. L. Onorato,
- C. Bachert,
- M. Barbolini,
- A. Bedbrook,
- L. Bjermer,
- J. Correia de Sousa,
- N. H. Chavannes,
- A. A. Cruz,
- E. De Manuel Keenoy,
- P. Devillier,
- J. Fonseca,
- S. Hun,
- T. Kostka,
- P. W. Hellings,
- M. Illario,
- J. C. Ivancevich,
- D. Larenas-Linnemann,
- J. Millot-Keurinck,
- D. Ryan,
- B. Samolinski,
- A. Sheikh,
- A. Yorgancioglu,
- I. Agache,
- S. Arnavielhe,
- M. Bewick,
- I. Annesi-Maesano,
- J. M. Anto,
- K. C. Bergmann,
- C. Bindslev-Jensen,
- S. Bosnic-Anticevich,
- J. Bouchard,
- D. P. Caimmi,
- P. Camargos,
- G. W. Canonica,
- V. Cardona,
- A. M. Carriazo,
- C. Cingi,
- E. Colgan,
- A. Custovic,
- R. Dahl,
- P. Demoly,
- G. De Vries,
- W. J. Fokkens,
- J. F. Fontaine,
- B. Gemicioğlu,
- N. Guldemond,
- Z. Gutter,
- T. Haahtela,
- B. Hellqvist-Dahl,
- E. Jares,
- G. Joos,
- J. Just,
- N. Khaltaev,
- T. Keil,
- L. Klimek,
- M. L. Kowalski,
- I. Kull,
- P. Kuna,
- V. Kvedariene,
- D. Laune,
- R. Louis,
- A. Magnan,
- J. Malva,
- E. Mathieu-Dupas,
- E. Melén,
- E. Menditto,
- M. Morais-Almeida,
- R. Mösges,
- J. Mullol,
- R. Murray,
- H. Neffen,
- R. O’Hehir,
- S. Palkonen,
- N. G. Papadopoulos,
- G. Passalacqua,
- J. L. Pépin,
- F. Portejoie,
- D. Price,
- B. Pugin,
- F. Raciborski,
- F. E. R. Simons,
- M. Sova,
- O. Spranger,
- C. Stellato,
- A. Todo Bom,
- P. V. Tomazic,
- M. Triggiani,
- A. Valero,
- E. Valovirta,
- O. VandenPlas,
- A. Valiulis,
- M. van Eerd,
- M. T. Ventura,
- M. Wickman,
- I. Young,
- T. Zuberbier,
- A. Zurkuhlen,
- A. Senn
Affiliations
- J. Bousquet
- Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site
- G. L. Onorato
- Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site
- C. Bachert
- Upper Airways Research Laboratory, ENT Department, Ghent University Hospital
- M. Barbolini
- Regione Emilia Romagna - Agenzia Sanitaria e Sociale, Reference Site of the European Innovation Partnership on Healthy and Active Ageing
- A. Bedbrook
- Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site
- L. Bjermer
- Department of Respiratory Medicine and Allergology, University Hospital
- J. Correia de Sousa
- Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho
- N. H. Chavannes
- Department of Public Health and Primary Care, Leiden University Medical Center
- A. A. Cruz
- ProAR – Nucleo de Excelencia em Asma, Federal University of Bahia
- E. De Manuel Keenoy
- Kronikgune, International Centre of Excellence in Chronicity Research Barakaldo
- P. Devillier
- Laboratoire de Pharmacologie Respiratoire UPRES EA220, Pôle des Maladies Respiratoires, Hôpital Foch, Suresnes Université Versailles Saint-Quentin
- J. Fonseca
- Center for Health Technology and Services Research- CINTESIS, Faculdade de Medicina, Universidade do Porto
- S. Hun
- Public Health Agency Northern Ireland
- T. Kostka
- Department of Geriatrics, Medical University of Lodz, Healthy Ageing Research Centre (HARC)
- P. W. Hellings
- Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven
- M. Illario
- Division for Health Innovation, Campania Region and Federico II University Hospital Naples (R&D and DISMET)
- J. C. Ivancevich
- Allergy and Immunology Department, Santa Isabel
- D. Larenas-Linnemann
- Clínica de Alergia, Asma y Pediatría, Hospital Médica Sur
- J. Millot-Keurinck
- Caisse Assurance Retraite et Santé Au Travail Languedoc-Roussillon (CARSAT-LR)
- D. Ryan
- Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh
- B. Samolinski
- Department of Prevention of Envinronmental Hazards and Allergology, Medical University of Warsaw
- A. Sheikh
- Asthma UK Centre for Applied Research, Centre of Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh
- A. Yorgancioglu
- Department of Pulmonology, Celal Bayar University
- I. Agache
- Faculty of Medicine, Transylvania University
- S. Arnavielhe
- Kyomed
- M. Bewick
- iQ4U Consultants Ltd
- I. Annesi-Maesano
- EPAR U707 INSERM, Paris and EPAR UMR-S UPMC, Paris VI
- J. M. Anto
- Centre for Research in Environmental Epidemiology (CREAL), ISGLoBAL
- K. C. Bergmann
- Comprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin
- C. Bindslev-Jensen
- Department of Dermatology and Allergy Centre, Odense University Hospital
- S. Bosnic-Anticevich
- Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District
- J. Bouchard
- Laval’s University
- D. P. Caimmi
- CHRU de Montpellier, Sorbonne Universités
- P. Camargos
- Department of Pediatrics, Medical School, Federal University of Minas Gerais
- G. W. Canonica
- CHRU de Montpellier, Sorbonne Universités
- V. Cardona
- Allergologia, S Medicina Interna, Hospital Vall d’Hebron
- A. M. Carriazo
- Regional Ministry of Health of Andalusia
- C. Cingi
- ENT Department, Medical Faculty, Eskisehir Osmangazi University
- E. Colgan
- Department of Health, Social Services and Public Safety
- A. Custovic
- Department of Pediatric, Imperial College London
- R. Dahl
- ProAR – Nucleo de Excelencia em Asma, Federal University of Bahia
- P. Demoly
- Department of Respiratory Diseases, Montpellier University Hospital
- G. De Vries
- Peercode DV
- W. J. Fokkens
- Department of Otorhinolaryngology, Academic Medical Centre
- J. F. Fontaine
- Allergist
- B. Gemicioğlu
- Department of Pulmonary Diseases, Cerrahpasa Faculty of Medicine, Istanbul University
- N. Guldemond
- Institute of Health Policy and Management iBMG, Erasmus University
- Z. Gutter
- University Hospital Olomouc – National eHealth Centre
- T. Haahtela
- Skin and Allergy Hospital, Helsinki University Hospital
- B. Hellqvist-Dahl
- Department of Respiratory Diseases, Odense University Hospital
- E. Jares
- Libra Foundation
- G. Joos
- Department of Respiratory Medicine, Ghent University Hospital
- J. Just
- Allergology Department, Centre de l’Asthme et des Allergies Hôpital d’Enfants Armand-Trousseau (APHP)
- N. Khaltaev
- GARD Chairman
- T. Keil
- Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin
- L. Klimek
- Center for Rhinology and Allergology
- M. L. Kowalski
- Department of Immunology, Rheumatology and Allergy, Medical University of Lodz, and HARC
- I. Kull
- Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet Stockholm
- P. Kuna
- Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz
- V. Kvedariene
- Clinic of Infectious, Chest Diseases, Dermatology and Allergology, Vilnius University
- D. Laune
- Kyomed
- R. Louis
- Department of Pulmonary Medicine, CHU Sart-Tilman
- A. Magnan
- Service de Pneumologie, UMR INSERM, UMR1087 and CNR 6291, l’institut du thorax, University of Nantes
- J. Malva
- Institute of Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra
- E. Mathieu-Dupas
- Kyomed
- E. Melén
- Sachs’ Children and Youth Hospital, Södersjukhuset, Stockholm and Institute of Environmental Medicine, Karolinska Institutet
- E. Menditto
- CIRFF, Federico II University
- M. Morais-Almeida
- Allergy and Clinical Immunology Department, Hospital CUF-Descobertas
- R. Mösges
- Institute of Medical Statistics, Informatics and Epidemiology, Medical Faculty, University of Cologne
- J. Mullol
- Clinical and Experimental Respiratory Immunoallergy, ENT Department, Hospital Clínic, IDIBAPS, CIBERES, Universitat de Barcelona
- R. Murray
- Medical Communications Consultant, MedScript Ltd
- H. Neffen
- Argentina Center for Allergy and Immunology, Alassia Children’s Hospital, Santa Fe
- R. O’Hehir
- Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, Monash University
- S. Palkonen
- EFA European Federation of Allergy and Airways Diseases Patients’ Associations
- N. G. Papadopoulos
- Center for Pediatrics and Child Health, Institute of Human Development, Royal Manchester Children’s Hospital, University of Manchester
- G. Passalacqua
- Allergy and Respiratory Diseases, IRCCS San Martino Hospital, IST-University of Genoa
- J. L. Pépin
- CHU Grenoble
- F. Portejoie
- Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site
- D. Price
- Observational and Pragmatic Research Institute
- B. Pugin
- Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven
- F. Raciborski
- Department of Prevention of Envinronmental Hazards and Allergology, Medical University of Warsaw
- F. E. R. Simons
- Department of Pediatrics and Child Health, Department of Immunology, Faculty of Medicine, University of Manitoba
- M. Sova
- University Hospital Olomouc
- O. Spranger
- Global Allergy and Asthma Platform GAAPP
- C. Stellato
- Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”, University of Salerno
- A. Todo Bom
- Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra
- P. V. Tomazic
- Department of ENT, Medical University of Graz
- M. Triggiani
- Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”, University of Salerno
- A. Valero
- Pneumology and Allergy Department Hospital Clínic, Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona
- E. Valovirta
- Pneumology and Allergy Department Hospital Clínic, Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona
- O. VandenPlas
- Department of Chest Medicine, Centre Hospitalier Universitaire UCL Namur, Université Catholique de Louvain
- A. Valiulis
- Vilnius University Medical Faculty, Clinic of Children’s Diseases and Institute of Public Health
- M. van Eerd
- Peercode DV
- M. T. Ventura
- Unit of Geriatric Immunoallergology, University of Bari Medical School
- M. Wickman
- Sachs’ Children and Youth Hospital, Södersjukhuset, Stockholm and Institute of Environmental Medicine, Karolinska Institutet
- I. Young
- Queen’s University Belfast
- T. Zuberbier
- Comprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin
- A. Zurkuhlen
- Gesundheitsregion KölnBonn - HRCB Projekt GmbH
- A. Senn
- EC-CNECT-H2, European Commission
- DOI
- https://doi.org/10.1186/s13601-017-0173-8
- Journal volume & issue
-
Vol. 7,
no. 1
pp. 1 – 16
Abstract
Abstract A Good Practice is a practice that works well, produces good results, and is recommended as a model. MACVIA-ARIA Sentinel Network (MASK), the new Allergic Rhinitis and its Impact on Asthma (ARIA) initiative, is an example of a Good Practice focusing on the implementation of multi-sectoral care pathways using emerging technologies with real life data in rhinitis and asthma multi-morbidity. The European Union Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS) has developed a checklist of 28 items for the evaluation of Good Practices. SUNFRAIL (Reference Sites Network for Prevention and Care of Frailty and Chronic Conditions in community dwelling persons of EU Countries), a European Union project, assessed whether MASK is in line with the 28 items of JA-CHRODIS. A short summary was proposed for each item and 18 experts, all members of ARIA and SUNFRAIL from 12 countries, assessed the 28 items using a Survey Monkey-based questionnaire. A visual analogue scale (VAS) from 0 (strongly disagree) to 100 (strongly agree) was used. Agreement equal or over 75% was observed for 14 items (50%). MASK is following the JA-CHRODIS recommendations for the evaluation of Good Practices.
Keywords
